Pavel Jeřábek

Experienced, innovative and strongly motivated quality assurance and regulatory affairs professional with proven tracked record of 10+ years in the medical cannabis industry.

• Member of ASTM International
• Member of Consorzio Italbiotec

• 2017 - Ghrelin receptor antagonism of morphine-induced conditioned place preference and behavioral
  and accumbens dopaminergic sensitization in rats; Jerabek P, Havlickova, Puskina N, Charalambous C,
  Lapka M, Kacer P, Sustkova-Fiserova M (Neurochemistry International; IF = 3,46)
• 2017 - Alterations in rat accumbens endocannabinoid and GABA content during fentanyl treatment: The
  role of ghrelin; Sustkova-Fiserova M, Charalambous C, Havlickova T, Lapka M, Jerabek P, Puskina N, Syslova
  K (Int. Journ. of Molecular Sciences; IF = 3,23)
• 2015 - Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus
  accumbens; Sustkova-Fiserova M, Jerabek P, Havlickova T, Syslova K, Kacer P (Psychopharmacology; IF =
  3,88)
• 2015 - Reward related neurotransmitter changes in a model of depression: An in vivo microdialysis study;
  Kucerova-Ruda J, Amchova P, Havlickova T, Jerabek P, Babinska Z, Kacer P, Syslova K, Sulcova A, Sustkova-
  Fiserova M (The World Journal of Biological Psychiatry; IF = 4,18)
• 2013 - Ghrelin receptor antagonism attenuates morphine-induced accumbens dopamine release and
  behavioral stimulation in rats Sustkova-Fiserova M, Jerabek P, Havlickova T, Kacer P, Krsiak M
  (Psychopharmacology; IF = 3,88)
• 2011 - Pharmacological modulation of the micturition pattern in normal and cyclophosphamide-pretreated
  conscious rats; Andersson M, Aronsson P, Giglio D, Wilhelmson A, Jerabek P, Tobin G (Autonomic
  Neuroscience-basic and clinical; IF=1,671)